Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLAG Regimen in R/R ALL
NCT05578378Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cladribine in acute lymphoblastic leukemia (ALL), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
cladribine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT05578378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05578378.